Arovella Therapeutics Limited (ASX:ALA) Secures $20M Placement
Arovella Therapeutics (ASX:ALA) announces a $20 million placement to fund Phase 1 clinical trials and solid tumour pipeline expansion.
Arovella Therapeutics (ASX:ALA) announces a $20 million placement to fund Phase 1 clinical trials and solid tumour pipeline expansion.
Radiopharm raises A$8 million from Lantheus, increasing its shareholding to 12.16% to support the clinical pipeline.
AdAlta Limited (ASX:1AD) to present its advancements in cell therapeutics at Biotech Showcase 2025 during JPMorgan Healthcare Week.
NTAW Holdings Limited (ASX:NTD) received termination notices for its Dunlop distribution agreements due to Goodyear’s brand sale to SRI.
Amaero International Limited secures A$38 million loan from EXIM to enhance U.S. manufacturing capabilities and create skilled jobs.
St George Mining commences a program to enhance processing for niobium and rare earths at its Araxá Project in Brazil.
Augustus Minerals announces significant findings from the VTEM survey at the Ti Tree Project, revealing key targets for further mineral exploration.
OncoSil Medical secures a $1.05 million R&D tax incentive to support advancements in its pancreatic cancer treatment technology.
Terrain Minerals Limited announces its strategic exploration focus for 2025, targeting gallium, gold, copper, and nickel.
Australian Mines Limited expands its Flemington Scandium Mineral Resource significantly, boosting growth potential in the critical minerals sector.